Literature DB >> 19294361

[Medical treatment of epilepsy: hidden dimensions].

J Bauer1, C Kronisch.   

Abstract

Treatment with antiepileptic drugs (AED) increases the chance of seizure control in patients with epilepsy. This control is best achieved with AED monotherapy in the early stages of the disease. In up to 28% of the remaining patients, complete seizure control is obtained with AED combination therapy. In our own retrospective studies, levetiracetam proved to be the most effective drug in add-on treatment of focal epilepsies. Seizure control for at least 6 months was seen in 22.8% of patients, and reduction of seizure frequency by more than 50% was achieved in 58.8%. One must however consider that up to 50% of all seizures are not recognized by the patients. This is especially the case in complex partial seizures and in seizures during sleep. Seizure control (as recognized by the patient) allows better social reintegration, e.g. by obtaining a driving license. In addition to AED therapy other epilepsy-related symptoms such as depression need diagnosis and treatment. Of all patients with epilepsy, 30-50% suffer from depression, but about 50% of these are not willing to start antidepressant drug therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19294361     DOI: 10.1007/s00115-008-2635-7

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  41 in total

1.  Results of treatment changes in patients with apparently drug-resistant chronic epilepsy.

Authors:  Anna L Luciano; Simon D Shorvon
Journal:  Ann Neurol       Date:  2007-10       Impact factor: 10.422

Review 2.  Clinical practice. Initial management of epilepsy.

Authors:  Jacqueline A French; Timothy A Pedley
Journal:  N Engl J Med       Date:  2008-07-10       Impact factor: 91.245

3.  Course of chronic focal epilepsy resistant to anticonvulsant treatment.

Authors:  J Bauer; W Burr
Journal:  Seizure       Date:  2001-06       Impact factor: 3.184

4.  Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial.

Authors:  A Marson; A Jacoby; A Johnson; L Kim; C Gamble; D Chadwick
Journal:  Lancet       Date:  2005 Jun 11-17       Impact factor: 79.321

Review 5.  Neuropsychological effects of epilepsy and antiepileptic drugs.

Authors:  P Kwan; M J Brodie
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

6.  Epilepsy: accuracy of patient seizure counts.

Authors:  Christian Hoppe; Annkathrin Poepel; Christian E Elger
Journal:  Arch Neurol       Date:  2007-11

7.  Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants.

Authors:  Kai Uwe Kühn; Boris B Quednow; Markus Thiel; Peter Falkai; Wolfgang Maier; Christian E Elger
Journal:  Epilepsy Behav       Date:  2003-12       Impact factor: 2.937

8.  The influence of subclinical epileptiform EEG discharges on driving behaviour.

Authors:  D G Kasteleijn-Nolst Trenité; J B Riemersma; C D Binnie; A M Smit; H Meinardi
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1987-08

9.  The long term retention of levetiracetam in a large cohort of patients with epilepsy.

Authors:  C Depondt; A W C Yuen; G S Bell; T Mitchell; M J Koepp; J S Duncan; J W Sander
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

10.  Tiagabine: efficacy and safety in partial seizures - current status.

Authors:  Jürgen Bauer; Déirdre Cooper-Mahkorn
Journal:  Neuropsychiatr Dis Treat       Date:  2008-08       Impact factor: 2.570

View more
  1 in total

1.  [Epilepsy and driving. Background, new German guidelines and comments].

Authors:  J Bauer; M Neumann
Journal:  Nervenarzt       Date:  2009-12       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.